REGN Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

$612.92  +5.53 (0.91%)
As of 06/24/2022 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/01/2001
Outstanding shares:  108,028,048
Average volume:  842,139
Market cap:   $65,615,156,075
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2730190

---

Valuation   (See tab for details)

---

PE ratio:   8.34
PB ratio:   3.30
PS ratio:   3.97
Return on equity:   39.84%
Net income %:   48.06%